Edition:
United States

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,000.00GBp
11:54am EDT
Change (% chg)

-37.50 (-0.93%)
Prev Close
4,037.50
Open
4,018.00
Day's High
4,030.00
Day's Low
3,977.00
Volume
1,807,702
Avg. Vol
3,867,761
52-wk High
4,640.50
52-wk Low
2,940.50

Select another date:

Mon, Jun 11 2018

Photo

Takeda shareholder group aims to block $62 billion Shire deal

TOKYO A group of Takeda Pharmaceutical Co Ltd shareholders is trying to build support to block the $62 billion acquisition of London-listed Shire Plc at an extraordinary general meeting, a leading member of the group told Reuters on Monday.

UPDATE 1-Takeda shareholder group aims to block $62 bln Shire deal

* Owns 1 pct of shares, needs one third of shareholders to block

UPDATE 1-Shareholders demand Japan's Takeda assuage fears over Shire deal

* Proposal says Shire deal could damage existing shareholders

CORRECTED-OFFICIAL-Shareholders demand Japan's Takeda assuage fears over Shire deal

TOKYO, May 29 Japanese drugmaker Takeda Pharmaceutical Co Ltd faces demands from disgruntled shareholders to put to a vote its $62-billion acquisition of London-listed Shire and do more to assuage concerns over the record-breaking deal.

UPDATE 2-Takeda sees lower annual profit, generics to erode cancer drug sales

* Takeda looking to strengthen pipeline by acquiring Shire (Adds executive comment, details)

Japan's Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry. | Video

Breakingviews - Takeda swallows big dose of risk to buy Shire

LONDON (Reuters Breakingviews) - Takeda Pharmaceutical is swallowing a big dose of risk to buy Shire. The Japanese drugmaker finally struck a deal to take control of its Irish peer, for $62 billion. It can just about make the math work, but requires big spending cuts and a load of debt.

UPDATE 5-Japan's Takeda clinches $62 bln Shire deal as pharma M&A rolls on

* Deal expected to close in first half of 2019 (Adds ratings agency reaction, further details)

FTSE helped by weaker pound; Shire, Virgin get takeover boost

MILAN, May 8 The FTSE edged up on Tuesday after a long weekend as a drop in the pound supported the internationally exposed index, while takeover activity boosted shares in drug-maker Shire and Virgin Money bank.

REFILE-Japan's Takeda agrees $62 billion takeover of Shire

LONDON, May 8 Takeda Pharma agreed to buy London-listed Shire for 46 billion pounds ($62.42 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.

Select another date: